Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease

Table 2 Comparison of serum levels of Homer1, SAH, Hcy and FGF23 among different subgroups

Items	SAP group (n = 48)	UAP group (n = 46)	AMI group (n = 43)	Control group (n = 145)	Z	P value
Homer1 (2^−△Ct)	2.85 ± 0.19*	3.09 ± 0.16*^#	3.37 ± 0.18*^#@	2.38 ± 0.21	368.785	< 0.001
SAH (nmol/L)	55.11 ± 4.01*	58.83 ± 4.12*^#	62.19 ± 4.39*^#@	45.03 ± 2.18	432.896	< 0.001
Hcy (μmol/L)	15.34 ± 1.23*	16.01 ± 1.28*^#	17.85 ± 1.34*^#@	13.01 ± 1.04	231.217	< 0.001
FGF23 (pg/mL)	38.29 ± 3.22*	43.29 ± 3.19*^#	49.83 ± 3.37*^#@	31.92 ± 3.29	183.352	< 0.001

Compared with the control group (*P < 0.05), compared with the SAP group (^#P < 0.05), Compared with the UAP group (^@P < 0.05)
SAP stable angina pectoris, UAP unstable angina pectoris, AMI acute myocardial infarction, SAH S-adenosyl-l-homocysteine, Hcy homocysteine, FGF fibroblast growth factors

ISSN: 1471-2261